Personalized medicine using 3D printing and semi-solid extrusion

• 1
  Key takeaways
• 2
  What 3D printing semi-solid extrusion actually does
• 3
  Why rheology decides whether the print works
• 4
  Nozzle, pressure and motion parameters that matter
• 5
  Drying and post-print handling
• 6
  What the geometry and dose control look like
• 7
  Where the process stops being the right choice
• 8
  Semi-solid extrusion against the other printing routes

Semi-solid extrusion sits between fused deposition and syringe dispensing. A formulation with the consistency of toothpaste is loaded into a barrel, pushed by a piston or a screw, and deposited through a small nozzle onto a build plate. No heater is required for the deposition step itself, which is why heat-sensitive actives survive the print.

The printed object is not a solid part. It is a wet green body held together by the yield stress of the paste. That distinction matters for every downstream decision: how fast you can print, how tall you can stack, how long the part must rest before handling, and what drying regime it needs.

Most systems on the bench use the same motion platform as a filament printer: a gantry, a stepper-driven extruder, and a controller running G-code. The difference is in the tool head and in the pressure control. A filament extruder grips and pushes a solid strand. A semi-solid head must maintain a constant volumetric flow from a material that changes viscosity as it moves.

That last point is the whole engineering problem. Flow rate depends on pressure, nozzle geometry and the shear history of the paste. If any of the three drifts, the deposited bead changes width, and the dose changes with it.

A printable paste needs shear thinning and a yield stress. Shear thinning means viscosity drops while the material is moving through the nozzle, so it flows at reasonable pressure. Yield stress means it stops moving and holds shape once the shear is removed. Without the second property, the bead spreads and the layers merge into a puddle.

Typical printable gels sit in a window where the storage modulus exceeds the loss modulus at low strain. Practically, that means the material behaves like a soft solid on the plate and like a liquid in the nozzle. Formulators tune this with thickeners, gelling agents and solids loading rather than with temperature.

Solids loading pushes the window in both directions. More active or excipient particles raise yield stress and improve shape retention, but they also raise the pressure needed to extrude. Past roughly 50–60 vol% solids, many pastes become difficult to push through a nozzle under 0.6 mm without clogging or phase separation.

The extrudate also swells as it leaves the nozzle. A 0.4 mm nozzle does not produce a 0.4 mm bead; die swell can add 10–30% depending on the formulation and the flow rate. Print paths must be compensated for that, or the walls will be thicker than the model predicts.

Nozzle diameter sets the resolution ceiling and the pressure floor at the same time. Small nozzles give finer walls but need higher pressure and clog more easily with particle-loaded pastes. For most pharmaceutical and dental pastes, Ø 0.4–0.8 mm is the working range. Below Ø 0.3 mm, filtration and deaeration of the formulation become mandatory.

Pressure control separates good machines from adequate ones. A constant-pressure feed produces a bead that narrows as the barrel empties and the paste stiffens. A screw or progressive-cavity feed gives closer to constant volumetric output, which keeps the bead width stable across a long print.

Motion parameters follow the same logic as filament printing but with tighter limits. Print speed typically runs 5–20 mm/s. Layer height is usually 60–80% of the nozzle bore. If speed rises above the point where the bead can be laid down without dragging, the nozzle pulls the wet wall instead of depositing on it.

Retraction and travel moves need attention. A wet paste strings badly. Most setups use a short reverse pulse plus a small lift on travel, and accept a visible seam rather than trying to hide it. Seam placement is a design decision, not an afterthought.

A freshly printed dose is mostly solvent or water and has almost no mechanical strength. It cannot be picked up, weighed or packaged without deforming. Drying is therefore a controlled process step with its own parameters, not a waiting period.

Two routes dominate. Air drying at ambient or slightly elevated temperature is gentle and works for thermolabile actives, but it is slow and can let the structure sag while it is still weak. Freeze drying holds shape well and gives a porous, fast-dissolving matrix, but it adds equipment and cycle time.

Shrinkage during drying is predictable enough to compensate in the model if the formulation is fixed. Volumetric shrinkage of 20–40% is common for water-based pastes. If the geometry is critical, the print is scaled up to land on the target dimension after drying.

Drying also affects content uniformity. Solvent migrating to the surface can carry dissolved active with it, leaving a gradient through the dose. Slow, uniform drying reduces that gradient. Fast drying at high temperature tends to make it worse.

Dose is determined by the extruded volume, and that volume comes from the toolpath. Change the infill percentage or the number of perimeter walls and the dose changes. This is why a single print file can carry several strengths: the geometry is the prescription.

That flexibility has a boundary. Below a certain dose, the geometry becomes too small to print reliably. A few milligrams of active in a paste with 10% drug loading means printing a structure of a few tens of milligrams, which is at the edge of what a 0.4 mm nozzle can place accurately.

Infill density is the main coarse control, and it is not linear. A 20% infill does not deliver exactly 20% of the solid-dose volume, because the perimeter walls contribute a fixed amount regardless of infill. Calibration curves per formulation are the practical answer.

For multi-drug doses, the cleanest route is separate print heads or separate cartridges, each with its own validated path. Mixing two actives in one paste invites compatibility and stability questions that are harder to answer than the printing itself.

Semi-solid extrusion is a poor fit for high-volume production. Cycle time per unit is minutes, not seconds, and the wet handling steps do not compress easily. If the requirement is millions of identical tablets, compaction still wins on cost and throughput.

It is also a poor fit when the active must be delivered as a hard, swallowable tablet with a long shelf life. Wet-printed structures are porous, hygroscopic and mechanically weak compared to compressed tablets. Stability studies often become the limiting factor, not the printing.

Shape retention limits overhangs. Because the material is supported by its own yield stress rather than by a printed support structure, unsupported spans beyond roughly 2–3 mm tend to sag. Large overhangs need either a support paste or a redesign.

Finally, the process needs formulation work before it needs hardware. Teams that buy a printer first and formulate later usually spend longer getting to a stable dose than teams that characterize the paste on a rheometer first.